Sequence
Last updated: 2024 Nov 18
Total hit(s): 6782
S.No.
1
39277919
SARS-CoV-2 detection in COVID-19 patients' sample using Wooden quoit conformation structural aptamer (WQCSA)-Based electronic bio-sensing system.
Biosens Bioelectron
2025 Jan 1
9.52
1
2
39254005
Genomic insights into mRNA COVID-19 vaccines efficacy: Linking genetic polymorphisms to waning immunity.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38575149
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
4
39489230
Structural basis of the C-terminal domain of SARS-CoV-2 N protein in complex with GMP reveals critical residues for RNA interaction.
Bioorg Med Chem Lett
2024 Dec 1
4.9
1
5
39468707
The characteristics of TCR CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccine recipients.
Virulence
2024 Dec
4.81
1
6
39262675
Co-infections of SARS-CoV-2 with respiratory syncytial virus and human influenza A in patients with symptoms of COVID-19 in Ghana: A retrospective study.
New Microbes New Infect
2024 Dec
1.6
1
7
39259045
Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages.
Emerg Microbes Infect
2024 Dec
5.84
1
8
38183475
Development of multiplex allele-specific RT-qPCR assays for differentiation of SARS-CoV-2 Omicron subvariants.
Appl Microbiol Biotechnol
2024 Dec
3.82
1
9
38916498
"Outlaw" mutations in quasispecies of SARS-CoV-2 inhibit replication.
Emerg Microbes Infect
2024 Dec
5.84
1
10
39188530
Structure of SARS-CoV-2 MTase nsp14 with the inhibitor STM957 reveals inhibition mechanism that is shared with a poxviral MTase VP39.
J Struct Biol X
2024 Dec
1
11
38377136
Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies.
Emerg Microbes Infect
2024 Dec
5.84
1
12
39525081
Revealing SARS-CoV-2 M(pro) mutation cold and hot spots: Dynamic residue network analysis meets machine learning.
Comput Struct Biotechnol J
2024 Dec
5.11
1
13
38717195
Humoral responses to multiple SARS-CoV-2 variants after two doses of vaccine in kidney transplant patients.
Virulence
2024 Dec
4.81
1
14
38882678
Dynamic expedition of leading mutations in SARS-CoV-2 spike glycoproteins.
Comput Struct Biotechnol J
2024 Dec
5.11
1
15
39502850
LPL Gene Mutation in Type 1 Familial Triglyceridemia Presenting as Recurrent Pancreatitis and Complicated by COVID19.
J Pediatr Genet
2024 Dec
1
16
39520393
Fitness of SARS-CoV-2 Omicron subvariants in respiratory and gastrointestinal cell lines as determined by RT-ddPCR and whole genome sequencing.
J Infect Dis
2024 Nov 9
4.73
1
17
39516327
Genomic Surveillance and Molecular Characterization of SARS-CoV-2 Variants During the Peak of the Pandemic in Turkiye.
Biochem Genet
2024 Nov 8
1
18
39516586
Detection of SARS-CoV-2 in wastewater as an earlier predictor of COVID-19 epidemic peaks in Venezuela.
Sci Rep
2024 Nov 8
4.12
1
19
39510121
Lower levels of household transmission of SARS-CoV-2 VOC Omicron compared to Wild-type: an interplay between transmissibility and immune status.
J Infect Dis
2024 Nov 8
4.73
1
20
39541975
The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity.
Structure
2024 Nov 8
9.2
1
21
39508163
Exploring coronavirus sequence motifs through convolutional neural network for accurate identification of COVID-19.
Comput Methods Biomech Biomed Engin
2024 Nov 7
0.76
1
22
39521256
Causal association between COVID-19 vaccination and thrombosis-related biomarkers/thrombosis/ischemic stroke: Mendelian randomization study.
J Stroke Cerebrovasc Dis
2024 Nov 7
1.7
1
23
39506608
A Novel Cell- and Virus-Free SARS-CoV-2 Neutralizing Antibody ELISA Based on Site-Specific Labeling Technology.
Anal Chem
2024 Nov 7
6.37
2
24
39510135
Convergent and divergent immune aberrations in COVID-19, post-COVID-19-Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.
Am J Physiol Cell Physiol
2024 Nov 7
3.52
1
25
39500906
A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2.
Signal Transduct Target Ther
2024 Nov 6
- n/a -
1